Labcorp Holdings Inc. (LH) is a publicly traded Healthcare sector company. As of May 20, 2026, LH trades at $254.87 with a market cap of $20.96B and a P/E ratio of 22.31. LH moved +0.39% today. Year to date, LH is +0.81%; over the trailing twelve months it is +1.56%. Its 52-week range spans $209.38 to $293.72. Analyst consensus is strong buy with an average price target of $310.78. Rallies surfaces LH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LH recently traded at $254.87. Market cap is $20.96B. P/E ratio is 22.31. Revenue is $14.14B.
| Metric | Value |
|---|---|
| Price | $254.87 |
| Market Cap | $20.96B |
| P/E Ratio | 22.31 |
| EPS | $11.36 |
| Dividend Yield | 0.72% |
| 52-Week High | $293.72 |
| 52-Week Low | $209.38 |
| Volume | 135.35K |
| Avg Volume | 0 |
| Revenue (TTM) | $14.14B |
| Net Income | $942.70M |
| Gross Margin | 28.83% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $13.95B | $877.70M | $10.54 |
| 2024 | $13.01B | $747.10M | $8.89 |
| 2023 | $12.16B | $419.20M | $4.80 |
| 2022 | $14.88B | $1.28B | $14.05 |
10 analysts cover LH: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $310.78.